Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-25-000008
Filing Date
2025-03-03
Accepted
2025-03-03 19:18:08
Documents
1
Period of Report
2025-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 7173
  Complete submission text file 0001765581-25-000008.txt   8757
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address JAZZ PHARMACEUTICALS 3170 PORTER DRIVE PALO ALTO CA 94304
Business Address
Patil Neena M (Reporting) CIK: 0001783908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 25700780